Goldman Sachs Group Inc Bridge Bio Pharma, Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,035,189 shares of BBIO stock, worth $75 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,035,189
Previous 2,051,973
0.82%
Holding current value
$75 Million
Previous $52.2 Million
6.89%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$931 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$926 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$556 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$459 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$228 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.46B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...